[1]
Kumar, S.; Pandey, A.K. Chemistry and biological activities of flavonoids: An overview. Sci. World J., 2013, 2013, 1-16.
[2]
Narayana, K.R.; Reddy, M.S.; Chaluvadi, M. Bioflavonoids classification, pharmacological, biochemical effects and therapeutic potential. Int. J. Pharmacol., 2001, 33(1), 2-16.
[3]
Patel, J.M. A review of potential health benefits of flavonoids. Lethbridge Undergrad. Res. J., 2008, 3, 2.
[4]
Rice-Evans, C.; Miller, N.; Paganga, G. Antioxidant properties of phenolic compounds. Trends Plant Sci., 1997, 2(4), 152-159.
[5]
Rice-evans, C.A.; Miller, N.J.; Bolwell, P.G. The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radic. Res., 1995, 22(4), 375-383.
[6]
Burda, S.; Oleszek, W. Antioxidant and antiradical activities of flavonoids. J. Agric. Food Chem., 2001, 49(6), 2774-2779.
[7]
Cao, G.; Sofic, E.; Prior, R.L. Antioxidant and pro-oxidant behavior of flavonoids: Structure-activity relationships. Free Radic. Biol. Med., 1997, 22(5), 749-760.
[8]
Van Acker, S.A.; Tromp, M.N.; Griffioen, D.H. Structural aspects of antioxidant activity of flavonoids. Free Radic. Biol. Med., 1996, 20(3), 331-342.
[9]
Merk index. 12th Edition ed. Merk Index. 8456.
[10]
Saija, A.; Scalese, M.; Lanza, M.; Marzullo, D.; Bonina, F.; Castelli, F. Flavonoids as antioxidant agents: Importance of their interaction with bio-membranes. Free Radic. Biol. Med., 1995, 19(4), 481-486.
[11]
Kessler, M.; Ubeaud, G.; Jung, L. Anti‐and pro‐oxidant activity of rutin and quercetin derivatives. J. Pharm. Pharmacol., 2003, 55(1), 131-142.
[12]
Guardia, T.; Rotelli, A.E.; Juarez, A.O.; Pelzer, L.E. Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Il farmaco, 2001, 56(9), 683-687.
[13]
Kim, D.W.; Hwang, I.K.; Lim, S.S.; Yoo, K.Y.; Li, H.; Kim, Y.S.; Kwon, D.Y.; Moon, W.K.; Kim, D.W.; Won, M.H. Germinated buckwheat extract decreases blood pressure and nitrotyrosine immunoreactivity in aortic endothelial cells in spontaneously hypertensive rats. Phytother. Res., 2009, 23(7), 993-998.
[14]
Ajay, M. Gilani, A-uH.; Mustafa, M.R. Effects of flavonoids on vascular smooth muscle of the isolated rat thoracic aorta. Life Sci., 2003, 74(5), 603-612.
[15]
Beretz, A. Cazenave. J-P. The effect of flavonoids on blood-vessel wall interactions. Prog. Clin. Biol. Res., 1988, 280, 187.
[16]
Grinberg, L.N.; Rachmilewitz, E.A.; Newmark, H. Protective effects of rutin against hemoglobin oxidation. Biochem. Pharmacol., 1994, 48(4), 643-649.
[17]
Formica, J.V.; Regelson, W. Review of the biology of Quercetin and related bioflavonoids [Review]. Food Chem. Toxicol., 1995, 33(12), 1061-1080.
[18]
Manach, C.; Williamson, G.; Morand, C.; Scalbert, A.; Rémésy, C. Bioavailability and bioefficacy of polyphenols in humans. Review of 97 bioavailability studies. Am. J. Clin. Nutr., 2005, 81(1), 230S-242S.
[19]
Graefe, E.U.; Wittig, J.; Mueller, S.; Riethling, A.K.; Uehleke, B.; Drewelow, B.; Pforte, H.; Jacobasch, G.; Derendorf, H.; Veit, M. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J. Clin. Pharmacol., 2001, 41(5), 492-499.
[20]
Erlund, I.; Kosonen, T.; Alfthan, G. Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur. J. Clin. Pharmacol., 2000, 56(8), 545-553.
[23]
Beaumont, K.; Webster, R.; Gardner, I. Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: Challenges to the discovery scientist. Curr. Drug Metab., 2003, 4(6), 461-485.
[24]
Yang, Y.-h.; Aloysius, H.; Inoyama, D.; Chen, Y.; Hu, L.-q. Enzyme-mediated hydrolytic activation of prodrugs. Acta
Pharmaceutica Sinica B., 2011, 1(3), 143-159. doi: 10.1016/j.apsb.
2011.08.001.
[25]
Baldisserotto, A.; Vertuani, S.; Bino, A.; De Lucia, D.; Lampronti, I.; Milani, R.; Gambari, R.; Manfredini, S. Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties. Bioorg. Med. Chem., 2015, 23(1), 264-271.
[26]
Abualhasan, M.; Jaradata, N.; Abu-Hasanb, N.; Almasri, M.; Rabbaa, A.; Abu Taha, A. Bioactivity of Viscum album extracts from olive and almond host plants in Palestine. Pharm. J., 2014, 6(2), 38.
[27]
Aulton, M.E. Pharmaceutics: The science of dosage form design. Churchill livingstone, 2002.
[29]
CBER, I. Q2A.; Guideline for Industry.; Text on Validation of
Analytical Procedures. March; 1995.
[30]
Guideline, I.H.T. Validation of analytical procedures. Text Methodology., Q2 (R1). 2005; 1.
[31]
Tejal, S.; Solanki, N.; Mahatma, O. Process validation: An essential in the pharmaceutical industry. Inter. J. Pharmace. Res. Develop., 2011, 3(10), 133-142.
[32]
US Pharmacopeial Convention.; Dissolution.; 2012, 711.
[33]
U.S. Pharmacopeia.; Buffer solutions.; 29.
[34]
Lakshmi, C.S.; Badarinath, A. An updated review of dissolution apparatus for conventional and novel dosage forms. Int. J. Pharma. Res. Rev., 2013, 2, 42-53.
[35]
Health UDo.; Services H. Guidance for industry: Dissolution
testing of immediate release solid oral dosage forms. Food and
Drug Administration Center for Drug Evaluation and Research
(CDER). 1997.
[37]
Bakshi, M.; Singh, S. Development of validated stability-indicating assay methods-critical review. J. Pharm. Biomed. Anal., 2002, 28(6), 1011-1040.
40
5
1
1